Search Prime Grants

NU51CK000328

Cooperative Agreement

Overview

Grant Description
Epidemiology and laboratory capacity for infectious diseases (ELC) - the Arkansas Department of Health will be applying to respond to a Notice of Funding Opportunity (NOFO) for the Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Cooperative Agreement.

This application is for the first year of the new, competitive 5-year CDC Cooperative Agreement with a performance period of August 1, 2024 – July 31, 2029.

This application represents a one-year funding request but will set the baseline for the following application years.

We have selected five cross-cutting emerging infectious disease components, five programs, and three projects to apply for, representing a total request of $7,970,463.35.

Of these funds, $3,580,654 is for a project which serves as a placeholder for additional funds should an acute outbreak of an emerging disease present itself.

As such, the maximum award we could receive outside of this placeholder would be $4,389,809.35.

These funds request support for 41 positions and represent the agency's largest funding source for acute infectious disease work.
Funding Goals
NOT APPLICABLE
Place of Performance
Arkansas United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the total obligations have increased 287953% from $2,044 to $5,887,794.
Arkansas Department Of Health was awarded ELC : Arkansas DOH Response to CDC NOFO Emerging Infectious Diseases Cooperative Agreement NU51CK000328 worth $5,887,794 from Center For Surveillance, Epidemiology, And Laboratory Services in August 2024 with work to be completed primarily in Arkansas United States. The grant has a duration of 5 years and was awarded through assistance program 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance. The Cooperative Agreement was awarded through grant opportunity Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
8/1/24
Start Date
7/31/29
End Date
24.0% Complete

Funding Split
$5.9M
Federal Obligation
$0.0
Non-Federal Obligation
$5.9M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to NU51CK000328

Transaction History

Modifications to NU51CK000328

Additional Detail

Award ID FAIN
NU51CK000328
SAI Number
NU51CK000328-779263135
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CPN0 CDC CENTER FOR SURVEILLANCE, EPIDEMIOLOGY, AND LABORATORY SERVICES
Awardee UEI
SYB9UJV328L9
Awardee CAGE
2J090
Performance District
AR-90
Senators
John Boozman
Tom Cotton
Modified: 9/24/25